INSULIN Act of 2026

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4189 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4189 To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 25, 2026 Mrs. Shaheen (for herself, Ms. Collins, Mr. Warnock, Mr. Kennedy, Ms. Rosen, Mr. Tuberville, Mr. King, Ms. Murkowski, Mr. Kelly, Mr. Grassley, Ms. Baldwin, and Mrs. Britt) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) Short Title.--This Act may be cited as the ``Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026'' or the ``INSULIN Act of 2026''. (b) Table of Contents.--The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. TITLE I--COMMERCIAL MARKET PATIENT PROTECTIONS Sec. 101. Requirements with respect to cost-sharing for certain insulin products. Sec. 102. Application to retiree and certain small group plans. Sec. 103. Administration. TITLE II--PHARMACY BENEFIT MANAGER TRANSPARENCY AND REBATE REFORM Sec. 201. Full rebate on insulin pass-through to plan. TITLE III--BIOSIMILAR BIOLOGICAL PRODUCT AND GENERIC DRUG COMPETITION AND AFFORDABILITY Sec. 301. Ensuring timely access to generics. Sec. 302. Expediting competitive biosimilar competition. Sec. 303. Insulin competition report. TITLE IV--PROGRAMS FOR PROVIDING AFFORDABLE INSULIN TO UNINSURED INDIVIDUALS Sec. 401. Pilot program for providin